At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Role of Oral and Intestinal Microbiota in Rheumatoid Arthritis (RA)
In Brief
A clinical study evaluating doxycycline and vancomycin for Rheumatoid Arthritis and 2 related conditions. Completed, enrolled 178 participants across 2 sites.
Detailed Summary
Rheumatoid arthritis (RA) is an inflammatory form of arthritis that causes joint pain and damage. RA attacks the lining of the joints (synovium), causing swelling that can result in aching and throbbing, and eventually deformity. Even though there have been many advances in the treatment of RA, psoriatic arthritis (PsA), and other inflammatory arthritis, doctors still do not know what causes this inflammation in joints. It is likely that RA occurs as a result of a complex combination of factors, including a person's genes; lifestyle choices, such as smoking and diet; and things in a person's environment, including bacteria or viruses. This study investigates the hypothesis that bacteria living in a person's mouth and/or intestinal tract are responsible, at least in part, for the development of Rheumatoid Arthritis. The investigators believe that by killing those bacteria with antibiotics, they might be able to understand how the immune system works and, maybe, what causes RA.
Study Details
Timeline
Interventions
doxycycline - 100 mg twice per day, for 2 months
vancomycin, 250 mg four times a day, for 2 weeks